Literature DB >> 32839034

Blood biomarkers for the diagnosis of hepatic steatosis in metabolic dysfunction-associated fatty liver disease.

Zhou Xu1, Hao Li2, Shen Tian2, Juan Wu2, Xin Li2, Zi-Li Liu2, Shu Li2, Yu-Ling Chen2, Jun Xiao2, Jia-Ying Wei2, Xin-Yu Liang2, Liang Ran3, Ling-Quan Kong4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32839034     DOI： 10.1016/j.jhep.2020.06.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data.

Authors:  Juan Wu; Shen Tian; Hao Li; Zhou Xu; Shu Li; Yu-Ling Chen; Xin-Yu Liang; Jun Xiao; Jing-Yu Song; Rui-Ling She; Chen-Yu Ma; Jun-Han Feng; Zhao-Xing Li; Zhi-Yu Jiang; Zi-Wei Zhang; Kai-Nan Wu; Ling-Quan Kong
Journal:  BMC Gastroenterol       Date:  2022-05-27       Impact factor: 2.847

Review 2.  Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Authors:  Jalpa Devi; Aimun Raees; Amna Subhan Butt
Journal:  World J Hepatol       Date:  2022-01-27

3.  The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome.

Authors:  Takumi Noda; Kentaro Kamiya; Nobuaki Hamazaki; Kohei Nozaki; Takafumi Ichikawa; Masashi Yamashita; Shota Uchida; Emi Maekawa; Tasuku Terada; Jennifer L Reed; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

4.  The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Yasser Fouad; Gamal Esmat; Reda Elwakil; Serag Zakaria; Ayman Yosry; Imam Waked; Maissa El-Razky; Wahid Doss; Magdy El-Serafy; Ebraheem Mostafa; Mahmood Anees; Mohamed A Sakr; Nadia AbdelAty; Ashraf Omar; Samy Zaki; Amgad Al-Zahaby; Hamdy Mahfouz; Maysaa Abdalla; Mahmoud Albendary; Abdel-Khalek Hamed; Ahmed Gomaa; Adel Hasan; Sherif Abdel-Baky; Medhat El Sahhar; Gamal Shiha; Dina Attia; Ebada Saeed; Enas Kamal; Shamardan Bazeed; Mai Mehrez; Shereen Abdelaleem; Yasmine Gaber; Mohammed Abdallah; Asmaa Salama; Doaa A Tawab; Shaymaa Nafady
Journal:  Saudi J Gastroenterol       Date:  2022 Jan-Feb       Impact factor: 2.485

5.  Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.

Authors:  Joon Ho Moon; Won Kim; Bo Kyung Koo; Nam H Cho
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

6.  Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.

Authors:  A Lum Han; Hee Kyung Lee
Journal:  Metabolites       Date:  2022-07-19

7.  Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.

Authors:  Gashaw Abebe; Daniel Ayanaw; Tiget Ayelgn Mengstie; Gashaw Dessie; Tabarak Malik
Journal:  SAGE Open Med       Date:  2022-09-19

8.  Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease.

Authors:  Tae-In Hwang; A-Lum Han
Journal:  Int J Environ Res Public Health       Date:  2021-12-13       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.